RESUMO
In this article, a group of experts in headache management of the Brazilian Headache Society developed through a consensus strategic measurements to treat a migraine attack in both the child and the adult. Particular emphasis was laid on the treatment of migraine in women, including at pregnancy, lactation and perimenstrual period.
Assuntos
Consenso , Transtornos de Enxaqueca/tratamento farmacológico , Adulto , Brasil , Criança , Feminino , Humanos , Masculino , Transtornos de Enxaqueca/etiologia , Gravidez , Complicações na Gravidez/tratamento farmacológicoRESUMO
ABSTRACT In this article, a group of experts in headache management of the Brazilian Headache Society developed through a consensus strategic measurements to treat a migraine attack in both the child and the adult. Particular emphasis was laid on the treatment of migraine in women, including at pregnancy, lactation and perimenstrual period.
RESUMO Neste artigo um grupo de especialistas no tratamento de cefaleia da Sociedade Brasileira de Cefaleia através de um consenso elaborou medidas estratérgicas para tratar uma crise de migrânea tanto na criança como no adulto. Uma enfase particular foi dada no tratamento da migranea na mulher, incluindo gravidez, lactação e período perimenstrual.
Assuntos
Humanos , Masculino , Feminino , Gravidez , Criança , Adulto , Consenso , Transtornos de Enxaqueca/tratamento farmacológico , Complicações na Gravidez/tratamento farmacológico , Brasil , Transtornos de Enxaqueca/etiologiaRESUMO
Objective The objective of this study was to prospectively evaluate the International Classification of Headache Disorders I (ICHD-I) diagnostic criteria for migraine in children and adolescents. Methods 150 pain diaries were analyzed during an initial consultation. The duration of migraine headache attacks were divided into 2 groups: Group I, for attacks lasting > 2 hours, and Group II, for attacks lasting < 2 hours.The two groups were statistically compared using Fisher’s exact test (p < 0.05). Results In this study, 51(34%) subjects were male and 99 (66%) were female, aged 7–15 years. Fisher’s exact test demonstrated that the ICHD-3 beta had a 58% sensitivity for Group I diagnoses and a 94% sensitivity for Group II diagnoses (p < 0.001). Conclusion The current ICHD-3 beta classification improves and advances migraine diagnosis in children and adolescents; however, more research is needed to identify additional characteristics of headache in this age group.
Objetivo O objetivo deste estudo foi avaliar prospectivamente os critérios diagnósticos da Classificação Internacional das Cefaleias 3 beta (CIC-3) de enxaqueca em crianças e adolescentes. Métodos 150 diários de dor foram analisados durante a consulta inicial. A duração dos episódios de enxaqueca foram divididos em dois grupos: Grupo I, para episódios com duração > 2 horas, e Grupo II, para os episódios < 2 horas. Os dois grupos foram comparados estatisticamente pelo teste exato de Fisher (p < 0,05). Resultados Neste estudo, 51 (34%) pacientes eram do sexo masculino e 99 (66%) eram do sexo feminino, com idade entre 7-15 anos. O teste exato de Fisher demonstrou que a CIC-3 beta teve sensibilidade de 58% para o diagnóstico do Grupo I e 94% para o diagnóstico do Grupo II (p < 0,001). Conclusão A atual classificação CIC-3 beta melhora e avança diagnóstico de enxaqueca em crianças e adolescentes; no entanto, mais pesquisas são necessárias para identificar as características adicionais de cefaléia nessa faixa etária.
Assuntos
Adolescente , Criança , Feminino , Humanos , Masculino , Classificação Internacional de Doenças , Transtornos de Enxaqueca/diagnóstico , Transtornos de Enxaqueca/classificação , Transtornos de Enxaqueca/complicações , Medição da Dor , Estudos Prospectivos , Sensibilidade e EspecificidadeRESUMO
OBJECTIVE: The objective of this study was to prospectively evaluate the International Classification of Headache Disorders I (ICHD-I) diagnostic criteria for migraine in children and adolescents. METHODS: 150 pain diaries were analyzed during an initial consultation. The duration of migraine headache attacks were divided into 2 groups: Group I, for attacks lasting > 2 hours, and Group II, for attacks lasting < 2 hours.The two groups were statistically compared using Fisher's exact test (p < 0.05). RESULTS: In this study, 51(34%) subjects were male and 99 (66%) were female, aged 7-15 years. Fisher's exact test demonstrated that the ICHD-3 beta had a 58% sensitivity for Group I diagnoses and a 94% sensitivity for Group II diagnoses (p < 0.001). CONCLUSION: The current ICHD-3 beta classification improves and advances migraine diagnosis in children and adolescents; however, more research is needed to identify additional characteristics of headache in this age group.